Evaluation of [68Ga]Ga-NODAGA-RGD for PET Imaging of Rat Autoimmune Myocarditis

The (68)Gallium-labeled 1,4,7-triazacyclononane-1-glutaric acid-4,7-diacetic acid conjugated radiolabelled arginine-glycine-aspartic acid peptide ([Ga-68]Ga-NODAGA-RGD) is a positron emission tomography (PET) tracer binding to cell surface receptor alpha(v)beta(3) integrin that is upregulated during angiogenesis and inflammation. We studied whether alpha(v)beta(3) targeting PET imaging can detect myocardial inflammation in a rat model of autoimmune myocarditis. To induce myocarditis, rats (n = 8) were immunized with porcine cardiac myosin in complete Freund's adjuvant on days 0 and 7. Control rats (n = 8) received Freund's adjuvant alone. On day 21, in vivo PET/CT imaging with [Ga-68]Ga-NODAGA-RGD followed by ex vivo autoradiography and immunohistochemistry were carried out. Inflammatory lesions were detected histologically in the myocardium of 7 out of 8 immunized rats. In vivo PET images showed higher [Ga-68]Ga-NODAGA-RGD accumulation in the myocardium of rats with inflammation than the non-inflamed myocardium of control rats (SUVmean 0.4 +/- 0.1 vs. 0.1 +/- 0.02; P = 0.00006). Ex vivo autoradiography and histology confirmed that [Ga-68]Ga-NODAGA-RGD uptake co-localized with inflammatory lesions containing alpha(v)beta(3) integrin-positive capillary-like structures. A non-specific [Ga-68]Ga-DOTA-(RGE)(2) tracer showed 76% lower uptake than [Ga-68]Ga-NODAGA-RGD in the inflamed myocardium. Our results indicate that alpha(v)beta(3) integrin-targeting [Ga-68]Ga-NODAGA-RGD is a potential PET tracer for the specific detection of active inflammatory lesions in autoimmune myocarditis.

Automated summary

The study demonstrated the potential of using alpha(v)beta(3)-targeting PET imaging with [Ga-68]Ga-NODAGA-RGD to specifically detect myocardial inflammation in a rat model of autoimmune myocarditis. The results showed higher accumulation of the tracer in inflamed myocardium compared to non-inflamed tissue, indicating its efficacy in identifying active inflammatory lesions.